718 related articles for article (PubMed ID: 27061322)
21. Proteomic analysis of red blood cells and the potential for the clinic: what have we learned so far?
D'Alessandro A; Zolla L
Expert Rev Proteomics; 2017 Mar; 14(3):243-252. PubMed ID: 28162022
[TBL] [Abstract][Full Text] [Related]
22. Potential blood biomarkers for stroke.
Laborde CM; Mourino-Alvarez L; Akerstrom F; Padial LR; Vivanco F; Gil-Dones F; Barderas MG
Expert Rev Proteomics; 2012 Aug; 9(4):437-49. PubMed ID: 22967080
[TBL] [Abstract][Full Text] [Related]
23. Individualized metabolomics: opportunities and challenges.
Misra B
Clin Chem Lab Med; 2020 Jun; 58(6):939-947. PubMed ID: 30951498
[TBL] [Abstract][Full Text] [Related]
24. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
Wang N; Zhu F; Chen L; Chen K
Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
[TBL] [Abstract][Full Text] [Related]
25. Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
Fawaz CN; Makki IS; Kazan JM; Gebara NY; Andary FS; Itani MM; El-Sayyed M; Zeidan A; Quartarone A; Darwish H; Mondello S
Expert Rev Proteomics; 2015; 12(6):637-50. PubMed ID: 26479122
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
Marcinkiewicz-Siemion M; Ciborowski M; Kretowski A; Musial WJ; Kaminski KA
Int J Cardiol; 2016 Sep; 219():156-63. PubMed ID: 27323342
[TBL] [Abstract][Full Text] [Related]
27. Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.
Wang Q; McCormick TS; Ward NL; Cooper KD; Conic R; Xu R
AMIA Annu Symp Proc; 2017; 2017():1734-1743. PubMed ID: 29854244
[TBL] [Abstract][Full Text] [Related]
28. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
Frédérich M; Pirotte B; Fillet M; de Tullio P
J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics in multiple sclerosis disease course and progression.
Bhargava P; Anthony DC
Mult Scler; 2020 Apr; 26(5):591-598. PubMed ID: 31965880
[TBL] [Abstract][Full Text] [Related]
30. Integration of proteomic and metabolomic profiling as well as metabolic modeling for the functional analysis of metabolic networks.
May P; Christian N; Ebenhöh O; Weckwerth W; Walther D
Methods Mol Biol; 2011; 694():341-63. PubMed ID: 21082444
[TBL] [Abstract][Full Text] [Related]
31. [Application of proteomics and metabolomics to study inherited kidney disorders: from big data to precision medicine].
Cervesato A; Raucci R; Buononato D; Marchese E; Capolongo G; Perna A; Capasso G; Zacchia M
G Ital Nefrol; 2020 Dec; 37(6):. PubMed ID: 33295706
[TBL] [Abstract][Full Text] [Related]
32. An overview of proteomic and metabolomic technologies and their application to pregnancy research.
Horgan RP; Clancy OH; Myers JE; Baker PN
BJOG; 2009 Jan; 116(2):173-81. PubMed ID: 19076949
[TBL] [Abstract][Full Text] [Related]
33. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
[TBL] [Abstract][Full Text] [Related]
34. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.
Castro-Santos P; Laborde CM; Díaz-Peña R
Clin Exp Rheumatol; 2015; 33(2):279-86. PubMed ID: 25572119
[TBL] [Abstract][Full Text] [Related]
35. Sarcoidosis: proteomics and new perspectives for improving personalized medicine.
Landi C; Carleo A; Cillis G; Rottoli P
Expert Rev Proteomics; 2018 Oct; 15(10):829-835. PubMed ID: 30251559
[TBL] [Abstract][Full Text] [Related]
36. Individual Biomarkers Using Molecular Personalized Medicine Approaches.
Zenner HP
ORL J Otorhinolaryngol Relat Spec; 2017; 79(1-2):7-13. PubMed ID: 28231575
[TBL] [Abstract][Full Text] [Related]
37. Advancing translational research and precision medicine with targeted proteomics.
Uzozie AC; Aebersold R
J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
[TBL] [Abstract][Full Text] [Related]
38. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
[TBL] [Abstract][Full Text] [Related]
39. Emerging applications of metabolomics in drug discovery and precision medicine.
Wishart DS
Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
[TBL] [Abstract][Full Text] [Related]
40. Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid.
Cicalini I; Rossi C; Pieragostino D; Agnifili L; Mastropasqua L; di Ioia M; De Luca G; Onofrj M; Federici L; Del Boccio P
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
